Aaron Ball ‘20 pitched Livongo Health (LVGO) on Monday, December 2, 2019. Livongo is a provider of an integrated suite of solutions for the healthcare industry sold through the employer and managed care channels. Livongo’s current solutions target the chronic conditions of diabetes, prediabetes and weight management, hypertension and behavioral health. Its platform provides cellular-connected devices, supplies, informed coaching, data science-enabled insights and improved access to medications to its members. Livongo currently boasts 207,815 members from 771 clients, which represent over 20% of Fortune 500 companies. Livongo has experienced rapid growth since its founding in 2014 by Bucknell alumnus Glen Tullman (‘81). It is seeking to continue its strong growth through the sale of additional solutions to existing clients and expansion into new markets, notably the fully-insured employer, government and international markets. The class voted to buy 350 shares of LVGO and fund the purchase with the sale of 32 shares of SPY.
Jack Baker ’20 pitched Campbell Soup Company (CPB) on November 4, 2019 to the Monday section of the Student Managed Investment Fund. Campbell’s Soup is a manufacturer and marketer of high-quality, branded food and beverage products which traces its heritage back 150 years. Campbell’s product segments are Meals & Beverages and Snacks, with 13 core brands generating roughly 80% of their yearly revenue. In 2019, Campbell’s Soup revamped their leadership team by hiring a new CEO, CFO, Head of Snacks, and Head of Meals & Beverages. In addition, Campbell’s is overhauling its portfolio by selling out of non-core businesses in an effort to reduce their amount of debt leverage. The class voted to buy 325 shares of Campbell Soup Company by selling 20 shares of SPY and 150 shares of XLP ETF.
Henry Charman ‘20 pitched CVS Health (CVS) on Monday, October 28, 2019. CVS Health is an integrated health services company providing a range of products and services to over 100 million commercial and government network clients. CVS’s offering portfolio includes cost management strategies for private and federal drug plan sponsors, a 68,000-store retail and specialty pharmacy network, and a variety of health insurance products serving over 42 million plan members following the company’s acquisition of insurer Aetna in November of 2018. Despite concern surrounding the 29% premium CVS paid in the $70 billion Aetna deal, CVS has been able to meet and even exceed near-term integration targets with Aetna in the first three quarters of 2019. Since hitting a 52-week low of $51.72 in March, CVS shares have recovered over 40% to $75.36 on December 6th. On October 28th, the class voted to fund the purchase of 225 shares of CVS with the sale of 50 shares of SPY.
James Weissenborn ’20 pitched Veeva Systems (VEEV) to the Monday section of the Student Managed Investment Fund on November 11, 2020. Veeva Systems provides application software and professional service solutions to pharmaceutical and life science companies across the globe. By creating easy to use, integrated products, Veeva Systems has a high retention rate of customers. Customers also continue to implement products from the expanding product line. Veeva Systems has begun offering solutions for industries outside of life sciences including chemicals, cosmetics and consumer goods. In the past four years, Veeva acquired three companies including Physicians World, Crossix and Zinc Ahead. Revenue is derived from subscription services and professional services, but the majority of revenue is generated from subscriptions. The class voted to buy 110 shares of Veeva Systems and sell 170 shares of the Health Care ETF, XLV.
Tyler Dagnino ’20 pitched Zebra Technologies (ZBRA) to the Monday section of the Student Managed Investment Fund on November 4, 2019. Zebra Technologies, or Zebra, designs, manufactures, and sells a range of automatic identification and data capture (AIDC) products worldwide. Zebra’s portfolio includes mobile computers, real-time location systems, and cloud-based platform subscriptions. Zebra is the industry leader in the AIDC market and should see continued success as they focus on providing organizations greater visibility and insights into their operations. The class voted to buy 70 shares of Zebra and sell out of the Technology Select Sector SPDR Fund (XLK) and Cisco (CSCO).
Soham Patel ’19 pitched Canadian National Railway (CNI) to the Tuesday section of the Student Managed Investment Fund on April 23, 2019. Canadian National Railway, or CN provides freight transportation services to a diverse list of clients across 19,500 miles of rail. By connecting three coasts, and mastering precision scheduled railroading, CN is considered the true backbone of the North American economy by servicing entire supply chain networks. This past year, CN invested capital in strategic capacities including Prince Rupert, North America’s fastest growing deep-sea port. Management has a record of returning at least 15% on invested capital and carefully manages foreign exchange risk. The majority of revenue is generated from transportation services, which have consistently increased despite economic fluctuations. The class voted to buy 110 shares of CNI and sell 40 shares of FedEx (FDX).
Jason Moy ’19 pitched Pfizer (PFE) to the Student Managed Investment Fund (SMIF) on April 22, 2019. Founded in 1849, PFE’s mission is to apply science and global resources to bring therapies to people that extend and significantly improve their lives. With over 92,400 employees in over 125 countries, PFE has a vast global presence. The company focuses on creating innovative health and essential health products. Innovative health products make up the bulk of revenue as PFE leads the pharmaceutical industry in revenue through its continuous pursuit of new inventive products and treatments. PFE also demonstrates stability in its portfolio of essential health with over-the-counter products sold worldwide. With consistent dividends and longstanding history, PFE is poised to have stable performance and strong profitability in the long run. As it stands, PFE is positioned to be a strong asset to shareholders with consistently growing dividends.